1
|
Börschel CS, Ortega-Alonso A, Havulinna AS, Jousilahti P, Salmi M, Jalkanen S, Veikko S, Niiranen T, Schnabel RB. Inflammatory proteomics profiling for prediction of incident atrial fibrillation. Heart 2023:heartjnl-2022-321959. [PMID: 36801832 DOI: 10.1136/heartjnl-2022-321959] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/09/2022] [Accepted: 02/03/2023] [Indexed: 02/19/2023] Open
Abstract
OBJECTIVE Atrial fibrillation (AF) has emerged as a common condition in older adults. Cardiovascular risk factors only explain about 50% of AF cases. Inflammatory biomarkers may help close this gap as inflammation can alter atrial electrophysiology and structure. This study aimed to determine a cytokine biomarker profile for this condition in the community using a proteomics approach. METHODS This study uses cytokine proteomics in participants of the Finnish population-based FINRISK cohort studies 1997/2002. Risk models for 46 cytokines were developed to predict incident AF using Cox regressions. Furthermore, the association of participants' C reactive protein (CRP) and N-terminal pro B-type natriuretic peptide (NT-proBNP) concentrations with incident AF was examined. RESULTS In 10 744 participants (mean age of 50.9 years, 51.3% women), 1246 cases of incident AF were observed (40.5% women). The main analyses, adjusted for participants' sex and age, suggested that higher concentrations of macrophage inflammatory protein-1β (HR=1.11; 95% CI 1.04, 1.17), hepatocyte growth factor (HR=1.12; 95% CI 1.05, 1.19), CRP (HR=1.17; 95% CI 1.10, 1.24) and NT-proBNP (HR=1.58; 95% CI 1.45, 1.71) were associated with increased risk of incident AF. In further clinical variable-adjusted models, only NT-proBNP remained statistically significant. CONCLUSION Our study confirmed NT-proBNP as a strong predictor for AF. Observed associations of circulating inflammatory cytokines were primarily explained by clinical risk factors and did not improve risk prediction. The potential mechanistic role of inflammatory cytokines measured in a proteomics approach remains to be further elucidated.
Collapse
Affiliation(s)
- Christin S Börschel
- Department of Cardiology, University Heart and Vascular Centre Hamburg-Eppendorf, Hamburg, Germany .,German Centre for Cardiovascular Research (DZHK), Partner Site Hamburg/Kiel/Lübeck, Hamburg, Germany
| | - Alfredo Ortega-Alonso
- Department of Public Health and Welfare, Finnish Institute for Health and Welfare, Helsinki, Finland.,Neuroscience Center, University of Helsinki, Helsinki, Finland.,Faculty of Sport and Health Sciences, University of Jyväskylä, Jyväskylä, Finland
| | - Aki S Havulinna
- Department of Public Health and Welfare, Finnish Institute for Health and Welfare, Helsinki, Finland.,Institute for Molecular Medicine Finland, FIMM - HiLIFE, Helsinki, Finland
| | - Pekka Jousilahti
- Department of Public Health and Welfare, Finnish Institute for Health and Welfare, Helsinki, Finland
| | - Marko Salmi
- MediCity Research Laboratory, Institute of Biomedicine and InFLAMES flagship, Turku, Finland
| | - Sirpa Jalkanen
- MediCity Research Laboratory, Institute of Biomedicine and InFLAMES flagship, Turku, Finland
| | - Salomaa Veikko
- Department of Public Health and Welfare, Finnish Institute for Health and Welfare, Helsinki, Finland
| | - Teemu Niiranen
- Department of Public Health and Welfare, Finnish Institute for Health and Welfare, Helsinki, Finland.,Department of Internal Medicine, University of Turku, Turku, Finland.,Division of Medicine, Turku University Hospital, Turku, Finland
| | - Renate B Schnabel
- Department of Cardiology, University Heart and Vascular Centre Hamburg-Eppendorf, Hamburg, Germany.,German Centre for Cardiovascular Research (DZHK), Partner Site Hamburg/Kiel/Lübeck, Hamburg, Germany
| |
Collapse
|
2
|
Cameron AJ, Romaniuk H, Orellana L, Dallongeville J, Dobson AJ, Drygas W, Ferrario M, Ferrieres J, Giampaoli S, Gianfagna F, Iacoviello L, Jousilahti P, Kee F, Moitry M, Niiranen TJ, Pająk A, Palmieri L, Palosaari T, Satu M, Tamosiunas A, Thorand B, Toft U, Vanuzzo D, Veikko S, Veronesi G, Wilsgaard T, Kuulasmaa K, Söderberg S. Combined Influence of Waist and Hip Circumference on Risk of Death in a Large Cohort of European and Australian Adults. J Am Heart Assoc 2020; 9:e015189. [PMID: 32602397 PMCID: PMC7670538 DOI: 10.1161/jaha.119.015189] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Background Waist circumference and hip circumference are both strongly associated with risk of death; however, their joint association has rarely been investigated. Methods and Results The MONICA Risk, Genetics, Archiving, and Monograph (MORGAM) Project was conducted in 30 cohorts from 11 countries; 90 487 men and women, aged 30 to 74 years, predominantly white, with no history of cardiovascular disease, were recruited in 1986 to 2010 and followed up for up to 24 years. Hazard ratios were estimated using sex‐specific Cox models, stratified by cohort, with age as the time scale. Models included baseline categorical obesity measures, age, total and high‐density lipoprotein cholesterol, systolic blood pressure, antihypertensive drugs, smoking, and diabetes mellitus. A total of 9105 all‐cause deaths were recorded during a median follow‐up of 10 years. Hazard ratios for all‐cause death presented J‐ or U‐shaped associations with most obesity measures. With waist and hip circumference included in the same model, for all hip sizes, having a smaller waist was strongly associated with lower risk of death, except for men with the smallest hips. In addition, among those with smaller waists, hip size was strongly negatively associated with risk of death, with ≈20% more people identified as being at increased risk compared with waist circumference alone. Conclusions A more complex relationship between hip circumference, waist circumference, and risk of death is revealed when both measures are considered simultaneously. This is particularly true for individuals with smaller waists, where having larger hips was protective. Considering both waist and hip circumference in the clinical setting could help to best identify those at increased risk of death.
Collapse
Affiliation(s)
- Adrian J. Cameron
- Global Obesity CentreInstitute for Health TransformationDeakin UniversityGeelongAustralia
| | - Helena Romaniuk
- Biostatistics UnitFaculty of HealthDeakin UniversityGeelongAustralia
| | - Liliana Orellana
- Biostatistics UnitFaculty of HealthDeakin UniversityGeelongAustralia
| | - Jean Dallongeville
- Unité d’Epidémiologie et de Santé PubliqueInserm‐U1167Institut Pasteur de LilleLilleFrance
| | - Annette J. Dobson
- School of Public HealthUniversity of QueenslandHerstonQueenslandAustralia
| | - Wojciech Drygas
- Department of Epidemiology CVD Prevention and Health PromotionCardinal Wyszynski National Institute of CardiologyWarsawPoland
| | - Marco Ferrario
- Department of Medicine and Surgery, Research Center in Epidemiology and Preventive MedicineUniversity of InsubriaVareseItaly
| | - Jean Ferrieres
- Department of CardiologyToulouse University School of MedicineToulouseFrance
| | - Simona Giampaoli
- Department of CardiovascularEndocrine‐Metabolic Diseases and AgingIstituto Superiore di SanitàRomeItaly
| | - Francesco Gianfagna
- Mediterranea CardiocentroNapoliItaly
- Department of Medicine and Surgery, Research Center in Epidemiology and Preventive MedicineUniversity of InsubriaVareseItaly
- University of InsubriaVareseItaly
| | - Licia Iacoviello
- Department of Epidemiology and PreventionIstituto di Ricovero e Cura a Carattere Scientifico NeuromedPozzilliItaly
- Department of Medicine and Surgery, Research Center in Epidemiology and Preventive MedicineUniversity of InsubriaVareseItaly
- University of InsubriaVareseItaly
| | - Pekka Jousilahti
- Department of Public Health SolutionsFinnish Institute for Health and WelfareHelsinkiFinland
| | - Frank Kee
- Centre for Public HealthInstitute for Health SciencesQueen’s University, School of Medicine, Dentistry and Biomedical SciencesBelfastNorthern Ireland
| | - Marie Moitry
- Department of Public HealthUniversity Hospital of StrasbourgFrance
- Department of Epidemiology and Public HealthUniversity of StrasbourgFrance
| | - Teemu J. Niiranen
- Department of Public Health SolutionsFinnish Institute for Health and WelfareHelsinkiFinland
- Department of MedicineTurku University Hospital and University of TurkuTurkuFinland
| | - Andrzej Pająk
- Department of Epidemiology and Population StudiesJagiellonian University Medical CollegeKrakówPoland
| | - Luigi Palmieri
- Department of CardiovascularEndocrine‐Metabolic Diseases and AgingIstituto Superiore di SanitàRomeItaly
| | - Tarja Palosaari
- Department of Public Health SolutionsFinnish Institute for Health and WelfareHelsinkiFinland
| | - Männistö Satu
- Department of Public Health SolutionsFinnish Institute for Health and WelfareHelsinkiFinland
| | - Abdonas Tamosiunas
- Department of Population StudiesInstitute of CardiologyLithuanian University of Health SciencesKaunasLithuania
| | - Barbara Thorand
- German Research Center for Environmental HealthInstitute of EpidemiologyHelmholtz Zentrum MünchenNeuherbergGermany
| | - Ulla Toft
- Center for Clinical Research and PreventionBispebjerg and Frederiksberg HospitalCopenhagenDenmark
| | | | - Salomaa Veikko
- Department of Public Health SolutionsFinnish Institute for Health and WelfareHelsinkiFinland
| | - Giovanni Veronesi
- Department of Medicine and Surgery, Research Center in Epidemiology and Preventive MedicineUniversity of InsubriaVareseItaly
| | - Tom Wilsgaard
- Department of Community MedicineThe Arctic University of NorwayTromsøNorway
| | - Kari Kuulasmaa
- Department of Public Health SolutionsFinnish Institute for Health and WelfareHelsinkiFinland
| | - Stefan Söderberg
- Department of Public Health and Clinical Medicine, and Heart CentreUmeå UniversityUmeåSweden
| |
Collapse
|